Phage Therapy
Phage Therapy is a pharmaceutical drug with 9 clinical trials. Currently 5 active trials ongoing.
Success Metrics
Phase Distribution
Phase Distribution
8
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
0.0%
0 of 2 finished
100.0%
2 ended early
5
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria
Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
Bacteriophage Therapy for Morganella Morganii Prosthetic Joint Infection
Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection
Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection
Clinical Trials (9)
Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria
Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
Bacteriophage Therapy for Morganella Morganii Prosthetic Joint Infection
Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection
Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection
Phage Therapy for the Treatment of Urinary Tract Infection
Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
Bacteriophage Therapy in Patients With Prosthetic Joint Infections
Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9